- Home
- ONON vs MEDP Comparison
ONON vs MEDP Comparison
Compare ONON & MEDP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ONON
- MEDP
- Stock Information
- Founded
- ONON 2010
- MEDP 1992
- Country
- ONON Switzerland
- MEDP United States
- Employees
- ONON N/A
- MEDP N/A
- Industry
- ONON Shoe Manufacturing
- MEDP Biotechnology: Commercial Physical & Biological Resarch
- Sector
- ONON Consumer Discretionary
- MEDP Health Care
- Exchange
- ONON Nasdaq
- MEDP Nasdaq
- Market Cap
- ONON 14.8B
- MEDP 13.4B
- IPO Year
- ONON 2021
- MEDP 2016
- Fundamental
- Price
- ONON $42.43
- MEDP $523.89
- Analyst Decision
- ONON Strong Buy
- MEDP Hold
- Analyst Count
- ONON 19
- MEDP 11
- Target Price
- ONON $64.53
- MEDP $421.60
- AVG Volume (30 Days)
- ONON 5.5M
- MEDP 299.0K
- Earning Date
- ONON 11-11-2025
- MEDP 10-22-2025
- Dividend Yield
- ONON N/A
- MEDP N/A
- EPS Growth
- ONON N/A
- MEDP 26.42
- EPS
- ONON 0.52
- MEDP 13.46
- Revenue
- ONON $3,417,915,703.00
- MEDP $2,231,787,000.00
- Revenue This Year
- ONON $30.44
- MEDP $19.06
- Revenue Next Year
- ONON $23.91
- MEDP $8.64
- P/E Ratio
- ONON $81.22
- MEDP $37.25
- Revenue Growth
- ONON 35.67
- MEDP 9.94
- 52 Week Low
- ONON $34.59
- MEDP $250.05
- 52 Week High
- ONON $64.05
- MEDP $547.15
- Technical
- Relative Strength Index (RSI)
- ONON 44.80
- MEDP 59.38
- Support Level
- ONON $41.31
- MEDP $494.17
- Resistance Level
- ONON $43.92
- MEDP $537.40
- Average True Range (ATR)
- ONON 1.46
- MEDP 16.68
- MACD
- ONON 0.05
- MEDP -2.75
- Stochastic Oscillator
- ONON 29.11
- MEDP 61.52
About ONON On Holding AG
On Holding AG is a premium performance sports brand rooted in technology, design, and impact. Its shoes, apparel, and accessories products are designed predominantly for athletic use, casual, or leisure purposes. It does not manufacture the products or the raw materials and relies instead on third-party suppliers and contract manufacturers. Geographically, it derives a majority of its revenue from the Americas and rest from Europe, Middle East and Africa and Asia-Pacific region.
About MEDP Medpace Holdings Inc.
Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.